尿石素A Urolithin A

FDA has no questions

In 2022, the European Food Safety Authority (EFSA) gave a positive opinion on the safety of Urolithin A for use in food supplements for the general adult population. The EFSA report emphasized no adverse effects under the proposed daily dose of up to 500 mg/day.

Application for the approval of Urolithin A as a novel food. Applicant: Amazentis SA. Status: In progress. Current Phase: Risk assessment In progress. [ACNFP 173rd meeting, 24-25 Sept 2025] The applicant proposes urolithin A in conventional foods, cereal bars, protein bars, nutrition bars targeting athletes, yoghurt products, specialised foods for adults only, including meal replacements, nutri…

Urolithin A is a synthetic version of urolithin A of the compound formed endogenously following consumption of ellagic acid and ellagitannins. Urolithin A is manufactured via chemical synthesis involving a chemical reaction between 2-bromo-5-hydroxybenzoic acid and resorcinol in the presence of sodium hydroxide and catalyst of cupric sulfate pentahydrate, followed by protonation of the resultin…

Timeline Urolithin A 60 軟膠囊 $2,899

本平臺非正面表列，並非平臺未載列品項即不得供為食品原料使用